Table 1 Baseline characteristics in patients with T1DM and controls; data are presented as mean ± standard deviation; GOT: glutamate – oxaloacetate - transaminase; GPT: glutamate –pyruvate – transaminase; GGT: gamma – glutamyl – transferase.

From: Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus

 

T1DM

Controls

p-value

Sex (m/f)

6/4

6/5

n.s.

Age (years)

46 ± 5

50 ± 1

n.s.

BMI (kg/m2)

25.5 ± 2

26.8 ± 3

n.s.

T1DM duration (years)

25 ± 11

  

Dose of basal insulin (IU/day)

21 ± 8.2

  

Fasting glucose (mg/dl)

130 ± 44

92 ± 8

0.026

HbA1c (%)

7.4 ± 0.6

5.3 ± 0.3

<0.001

Creatinine (mg/dl)

0.80 ± 0.2

0.80 ± 0.14

n.s.

GOT (mg/dl)

28 ± 8

24 ± 7

n.s.

GPT (mg/dl)

27 ± 7

24 ± 7

n.s.

GGT (mg/dl)

19 ± 7

19 ± 14

n.s.

Triglycerides (mg/dl)

113 ± 21

149 ± 45

n.s.

Cholesterol (mg/dl)

180 ± 40

205 ± 36

n.s.

HDL–Cholesterol (mg/dl)

67 ± 20

60 ± 15

n.s.

LDL–Cholesterol (mg/dl)

90 ± 23

117 ± 34

0.049

Back to article page